Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Burt's Pharmacy, LLC
483
•Burt's Pharmacy, LLC•October 7, 2022

Burt's Pharmacy, LLC – FDA 483, Oct 7, 2022

Record Details

During an inspection from October 4-7, 2022, the FDA issued a Form 483 to Burt's Pharmacy, LLC, a producer of nonsterile drugs, citing significant deficiencies in its manufacturing processes. The observations indicate potential violations of the Federal Food, Drug, and Cosmetic Act, particularly concerning drug quality and control.Key issues included the use of non-pharmaceutical grade components in drug formulations, such as those for Meperidine HCl and Dyclonine HCl, without adequate assurance of their microbiological or chemical quality. The inspection also revealed widespread problems with cross-contamination prevention. This included finding loose powder and residue on 'clean' capsule equipment and inside supposedly clean hoods, along with the use of cleaning agents without proof of their effectiveness against hazardous compounds like hormones and potent drugs. Damaged equipment, such as spatulas and mixing containers with rough, non-cleanable surfaces, and even corroded cleaning brushes, further compromised product integrity.Furthermore, Burt's Pharmacy released a Liothyronine (T3) capsule lot despite potency test results indicating it failed to meet finished drug specifications, lacking scientific justification for its release. Finally, insanitary conditions were noted, including the presence of a live spider in the hazardous production room and an exterior door gap that could allow vermin entry. The firm is expected to address these observations by implementing comprehensive corrective and preventive actions to ensure compliance and drug safety.

Company
Burt's Pharmacy, LLC
Inspection date
October 7, 2022
Product type
Drugs
Office
Los Angeles District Office
Person
  • Nicholas L. Hunt (Senior CSO, Investigator)
View Company Profile

ID · 1a66aecc-0850-467e-86c7-f6d3d5827034

Violation Codes3
21 U.S.C. 324(a)(4)FD&C Act 905(j)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Burt's Pharmacy, LLC
  • STATE_REFERRAL_LETTER - 2022-10-04October 4, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Burt's Pharmacy, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.